These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 6130799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE.
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [Abstract] [Full Text] [Related]

  • 5. Some adverse effects of antipsychotics: prevention and treatment.
    Lader M.
    J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 8. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
    Engel J, Liljequist S, Goldstein M.
    Adv Biochem Psychopharmacol; 1980 Sep; 23():387-95. PubMed ID: 6104913
    [No Abstract] [Full Text] [Related]

  • 9. [Tardive dyskinesias].
    Mignot G.
    Encephale; 1983 Sep; 9(2):151-66. PubMed ID: 6139271
    [Abstract] [Full Text] [Related]

  • 10. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001 Sep; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Movement disorders induced by neuroleptic therapy].
    Almeida R, Santos MV.
    Acta Med Port; 1993 Jun; 6(6):239-44. PubMed ID: 8103618
    [Abstract] [Full Text] [Related]

  • 13. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.
    See RE, Chapman MA.
    Crit Rev Neurobiol; 1994 Jun; 8(1-2):85-124. PubMed ID: 7907282
    [Abstract] [Full Text] [Related]

  • 14. Animal models of tardive dyskinesia--a review.
    Kulkarni SK, Naidu PS.
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [Abstract] [Full Text] [Related]

  • 15. An overview of side effects caused by typical antipsychotics.
    Arana GW.
    J Clin Psychiatry; 2000 Apr; 61 Suppl 8():5-11; discussion 12-3. PubMed ID: 10811237
    [Abstract] [Full Text] [Related]

  • 16. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
    Putzhammer A, Perfahl M, Pfeiff L, Müller JL.
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
    [Abstract] [Full Text] [Related]

  • 17. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J, Targum SD.
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ, Tarsy D.
    Adv Biochem Psychopharmacol; 1980 Dec; 24():451-5. PubMed ID: 6105793
    [No Abstract] [Full Text] [Related]

  • 19. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults.
    Lee PE, Sykora K, Gill SS, Mamdani M, Marras C, Anderson G, Shulman KI, Stukel T, Normand SL, Rochon PA.
    J Am Geriatr Soc; 2005 Aug; 53(8):1374-9. PubMed ID: 16078964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.